Verve Therapeutics Stock Price Prediction

VERV Stock  USD 16.29  0.76  4.46%   
At this time, the rsi of Verve Therapeutics' share price is at 56. This entails that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Verve Therapeutics' stock, making its price go up or down.

Oversold Vs Overbought

56

 
Oversold
 
Overbought
Verve Therapeutics stock price prediction is an act of determining the future value of Verve Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Verve Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Verve Therapeutics and does not consider all of the tangible or intangible factors available from Verve Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Verve Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Verve Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.83)
EPS Estimate Current Year
(3.07)
EPS Estimate Next Year
(3.25)
Wall Street Target Price
51.71
EPS Estimate Current Quarter
(0.82)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Verve Therapeutics based on different types of headlines from major news networks to social media. The Verve stock price prediction module provides an analysis of price elasticity to changes in media outlook on Verve Therapeutics over a specific investment horizon. Using Verve Therapeutics hype-based prediction, you can estimate the value of Verve Therapeutics from the perspective of Verve Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Verve Therapeutics using Verve Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Verve using crowd psychology based on the activity and movement of Verve Therapeutics' stock price.

Verve Therapeutics Short Interest

A significant increase or decrease in Verve Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Verve. Short interest can provide insight into the potential direction of Verve Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long Verve Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Verve Therapeutics and may potentially protect profits, hedge Verve Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA
14.5018
Short Percent
0.2044
Short Ratio
12.28
Shares Short Prior Month
12.4 M
50 Day MA
13.1852

Verve Therapeutics Hype to Price Pattern

Investor biases related to Verve Therapeutics' public news can be used to forecast risks associated with an investment in Verve. The trend in average sentiment can be used to explain how an investor holding Verve can time the market purely based on public headlines and social activities around Verve Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Verve Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Verve Therapeutics.

Verve Therapeutics Implied Volatility

    
  90.11  
Verve Therapeutics' implied volatility exposes the market's sentiment of Verve Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Verve Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Verve Therapeutics stock will not fluctuate a lot when Verve Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Verve Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Verve Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Verve because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Verve Therapeutics after-hype prediction price

    
  USD 16.54  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Verve Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Verve Stock please use our How to Invest in Verve Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Verve Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Verve Therapeutics in the context of predictive analytics.
Intrinsic
Valuation
LowRealHigh
14.6622.4327.57
Details
Naive
Forecast
LowNextHigh
12.4117.5422.68
Details
10 Analysts
Consensus
LowTargetHigh
40.2444.2249.08
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.85-0.74-0.6
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Verve Therapeutics. Your research has to be compared to or analyzed against Verve Therapeutics' peers to derive any actionable benefits. When done correctly, Verve Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Verve Therapeutics.

Verve Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Verve Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Verve Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Verve Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Verve Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Verve Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Verve Therapeutics' historical news coverage. Verve Therapeutics' after-hype downside and upside margins for the prediction period are 11.40 and 21.68, respectively. We have considered Verve Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
16.29
16.54
After-hype Price
21.68
Upside
Verve Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Verve Therapeutics is based on 3 months time horizon.

Verve Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Verve Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Verve Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Verve Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.69 
5.14
  0.25 
  0.15 
8 Events / Month
4 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
16.29
16.54
1.53 
1,428  
Notes

Verve Therapeutics Hype Timeline

Verve Therapeutics is at this time traded for 16.29. The entity has historical hype elasticity of 0.25 and average elasticity to hype of competition of 0.15. Verve is projected to increase in value after the next headline with the price projected to jump to 16.54 or above. The average volatility of media hype impact on the company stock price is over 100%. The price increase on the next news is projected to be 1.53% whereas the daily expected return is at this time at 0.69%. The volatility of related hype on Verve Therapeutics is about 2318.8% with expected price after next announcement by competition of 16.44. The company reported the previous year's revenue of 11.76 M. Net Loss for the year was (200.07 M) with loss before overhead, payroll, taxes, and interest of (128.15 M). Given the investment horizon of 90 days the next projected press release will be in about 8 days.
Check out Verve Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Verve Stock please use our How to Invest in Verve Therapeutics guide.

Verve Therapeutics Related Hype Analysis

Having access to credible news sources related to Verve Therapeutics' direct competition is more important than ever and may enhance your ability to predict Verve Therapeutics' future price movements. Getting to know how Verve Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Verve Therapeutics may potentially react to the hype associated with one of its peers.

Verve Therapeutics Additional Predictive Modules

Most predictive techniques to examine Verve price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Verve using various technical indicators. When you analyze Verve charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Verve Therapeutics Predictive Indicators

The successful prediction of Verve Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Verve Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Verve Therapeutics based on analysis of Verve Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Verve Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Verve Therapeutics's related companies.

Story Coverage note for Verve Therapeutics

The number of cover stories for Verve Therapeutics depends on current market conditions and Verve Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Verve Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Verve Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Verve Therapeutics Short Properties

Verve Therapeutics' future price predictability will typically decrease when Verve Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Verve Therapeutics often depends not only on the future outlook of the potential Verve Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verve Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding64.2 M
Cash And Short Term Investments624 M
When determining whether Verve Therapeutics is a strong investment it is important to analyze Verve Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verve Therapeutics' future performance. For an informed investment choice regarding Verve Stock, refer to the following important reports:
Check out Verve Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Verve Stock please use our How to Invest in Verve Therapeutics guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Verve Stock analysis

When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stocks Directory
Find actively traded stocks across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Verve Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verve Therapeutics. If investors know Verve will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verve Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.12)
Revenue Per Share
0.183
Quarterly Revenue Growth
4.083
Return On Assets
(0.19)
Return On Equity
(0.35)
The market value of Verve Therapeutics is measured differently than its book value, which is the value of Verve that is recorded on the company's balance sheet. Investors also form their own opinion of Verve Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Verve Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verve Therapeutics' market value can be influenced by many factors that don't directly affect Verve Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verve Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verve Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verve Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.